[CLSTR]
< Back to situation

[REVISION HISTORY]

OpenAI lawsuit and ChatGPT Health rollout under scrutiny

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-07-26 15:18 UTC → 2026-07-31 15:50 UTC · added removed

OpenAI lawsuit and ChatGPT Health rollout under scrutiny

The lawsuit civil suit filed by Florida pastor Scott Winters on July 21 2026 alleges that ChatGPT‑4o down‑rated his ChatGPT‑4o’s advice to stay home after reporting dizziness and groin pain, urging him to stay home, which the plaintiff says led pain contributed to a life‑threatening pulmonary embolism and emergency hospitalization. The complaint, lodged in San Francisco Superior Court and naming OpenAI CEO Sam Altman, seeks embolism, prompting a request for damages and an injunction to suspend halt the newly launched ChatGPT Health feature until independent safety certification is obtained. Reporting on July 24 added further detail: the civil suit claims OpenAI negligently practiced medicine without a license, labeling the case the first physical‑injury claim tied to AI‑generated medical advice. OpenAI reiterated maintains that ChatGPT the chatbot is a general‑information tool, not a medical device, and its terms direct users to consult qualified professionals seek professional care for urgent concerns. The same day the lawsuit was filed, issues. OpenAI rolled out completed a nationwide rollout of “Health in ChatGPT,” a feature that lets ChatGPT” on July 23 2026, allowing U.S. adults to link Apple Health, electronic‑medical‑record systems and other wellness apps so the chatbot model can reference personal data when answering health queries. The service runs on GPT‑5.6 Sol for paid tiers and GPT‑5.5 Instant for free users, with OpenAI claiming reporting performance on its internal HealthBench benchmark meets at or exceeds above clinician levels. Nationwide rollout completed on July 23 2026. Weekly health queries now exceed 300 million worldwide, but worldwide. By July 30 2026, U.S. healthcare professionals warned that patients might treat AI‑generated responses as medical advice, raising privacy, liability consent, data‑security and clinical‑reasoning concerns remain prominent. patient‑provider relationship concerns. Simultaneously, scientific studies offered conflicting assessments of AI performance: a Nature Medicine paper found general‑purpose models (ChatGPT, Claude, Gemini) outperformed a specialized model (OpenEvidence), while a later JAMA study rated OpenEvidence higher on accuracy, utility and verifiability. The divergent findings underscore calls for transparent, independent evaluation of AI health tools before broader clinical adoption.

Versions

  1. 2026-07-31 15:50 UTC OpenAI lawsuit and ChatGPT Health rollout under scrutiny
  2. 2026-07-26 15:18 UTC OpenAI lawsuit and ChatGPT Health rollout

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.